We noticed you are on our UK page. Want to switch regions? Choose from the options:

Dr Philip Camilleri
/content/dam/asset-migration/headshots/uk-doctor-headshots/UK_Oncology_Headshot_GA_Dr Philip Camilleri.jpg

Dr Philip Camilleri

Dr Philip Camilleri
MD, MRCP, FRCR, Clinical Oncologist

Languages spoken

English, Italian, Maltese, French

Expert in

Urology, prostate disease & cancer, testicular, bladder, urological oncology, bone therapy, hormone therapy and chemotherapy.

Overview

Centres

Oxford
Oxford

Peters Way, Sandy Lane West, Oxford, OX4 6LB

51.7239071200697, -1.2145938932540707
/uk/our-centres/oxford
Milton Keynes
Milton Keynes

GenesisCare, Sunrise Parkway, Linford Wood, East, Milton Keynes MK14 6LS, UK

52.05838, -0.76101
/uk/our-centres/milton-keynes

Specialises in

Prostate cancer
Condition
Condition/Cancer
Condition/Cancer/Prostate cancer

Treatments

Chemotherapy
Service
Service/Cancer
Service/Cancer/Medical oncology
Service/Cancer/Medical oncology/Chemotherapy
MR linac
Service
Service/Cancer
Service/Cancer/Radiotherapy
Service/Cancer/Radiotherapy/MR Linac
MRIdian
Service
Service/Cancer
Service/Cancer/Radiotherapy
Service/Cancer/Radiotherapy/MRIdian
Stereotactic ablative radiotherapy (SABR)
Service
Service/Cancer
Service/Cancer/Radiotherapy
Service/Cancer/Radiotherapy/Stereotactic ablative radiotherapy

Special clinical interest in urology, prostate disease & cancer, testicular, bladder, urological oncology, bone therapy, hormone therapy and chemotherapy.

Dr Camilleri was appointed as Consultant Clinical Oncologist in 2006 having trained in clinical oncology in Oxford. He specialises in urological cancers – specifically prostate, bladder, renal and testicular cancers – and provides chemotherapy, hormonal as well as radiotherapy treatment to cover all situations.

He is involved in research for most urological cancers and has launched and led on numerous national studies in Oxford. Dr Camilleri set up the prostate brachytherapy service in Oxford in 2013. He is the Lead Clinician for the urological oncology multi-disciplinary team at the Churchill Hospital, Oxford.

Awards recieved

  • Kay Fellowship awarded by the Royal College of Radiologists 2013

Clinical interests

  • Technical radiotherapy with brachytherapy
  • Stereotactic hypofractionated radiotherapy
  • Image-guided therapy as well as targeted therapy using advanced imaging techniques

Professional memberships

  • Member of the Royal College of Physicians (MRCP)
  • Fellow of the Royal College of Radiologists (FRCR)
  • Member of the Medical Defence Union (MDU)